Convolutional neural networks for prostate cancer detection, classification, and segmentation: A systematic review and bibliometric analysis

卷积神经网络在前列腺癌检测、分类和分割中的应用:系统综述和文献计量分析

阅读:1

Abstract

BACKGROUND: Prostate cancer represents the second most common malignancy among men globally, necessitating accurate diagnostic methodologies for optimal patient outcomes. Convolutional neural networks (CNNs), a core deep learning methodology, have emerged as transformative technologies for automated prostate cancer detection, classification, and segmentation across multiple imaging modalities. MATERIALS AND METHODS: A systematic review following PRISMA guidelines was conducted across Web of Science, Scopus, and PubMed databases (January 2020-December 2025). CNN-based classification architectures were analyzed across ResNet, Vision Transformer, DenseNet, Xception, ConvNeXT, and Swin Transformer implementations, with comparative evaluation of accuracy and transfer learning performance. Object detection and segmentation approaches were examined across U-Net variants, R-CNN family algorithms, and YOLO-based implementations. Hyperparameter optimization strategies were assessed. Explainable AI methodologies including SHAP, Grad-CAM, DiCE, and LIME were evaluated for clinical interpretability and spatial localization accuracy. RESULTS: Analysis of 320 publications revealed peak research activity in 2024 (63 publications, 19.7%). The United States led with 58 publications (18.1%), followed by China with 55 (17.2%). Multiparametric MRI constituted the primary imaging modality (42.5%), followed by histopathology (28.1%), ultrasound (14.1%), and PET imaging (9.4%). Vision Transformer models demonstrated the highest classification accuracy among evaluated architectures, while U-Net variants dominated segmentation applications with consistently high Dice coefficients. SHAP emerged as the most frequently adopted explainability method across the reviewed studies. CONCLUSIONS: CNN-based prostate cancer detection, classification, and segmentation demonstrate promise for improving diagnostic accuracy and clinical workflow efficiency, though challenges in dataset standardization, regulatory compliance, and clinical integration remain to be addressed.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。